Proteolysis

Proteolysis designates the set of enzymatic reactions hydrolyzing peptide bonds between amino acids, progressively fragmenting a protein or peptide into smaller pieces down to free amino acids. It is one of the fundamental pathways of molecular physiology: dietary digestion, cellular protein turnover, peptide hormone maturation, signaling pathway regulation, apoptosis, immunity, tissue remodeling.

Proteolysis is catalyzed by proteases, classified by catalytic mechanism (serine, cysteine, aspartyl, metallo-, threonine proteases) and mode of action (endopeptidases cleaving mid-chain, exopeptidases cleaving at N- or C-terminal ends). In human physiological conditions, several hundred proteases coexist and cooperate in complex cascades: digestive proteases (trypsin, chymotrypsin, pepsin), plasma proteases (thrombin, plasmin, complement cascade), intracellular proteases (apoptosis caspases, 26S proteasome), membrane proteases (ACE, DPP-4, neprilysin).

For a research peptide, proteolysis represents both a challenge and an object of study. Challenge: in biological media (serum, plasma, cell lysate, tissues), unprotected native peptides typically have a half-life of seconds to minutes. DPP-4 cleaves native GLP-1 in 1-2 minutes, neprilysin degrades natriuretic peptides in 5-10 minutes. This vulnerability mandates designing resistant analogs or using protease inhibitors during experimentation.

Object of study: controlled proteolysis is a major analytical tool. Tryptic digestion in proteomics cuts proteins into peptides of optimal size for MS/MS identification. Amino acid analysis by total hydrolysis (6N HCl, 110°C, 24h) quantifies composition. In vitro stability studies in biological media (human serum, murine plasma, tissue homogenate) measure degradation rate of a candidate peptide and guide analog design.

In RUO peptide research, documenting a peptide's proteolysis resistance is a central parameter: it conditions experimental reproducibility, validity of in vivo pharmacokinetic studies and relevance of in vitro dose-response curves.